ECSP045142A - Combinacion farmaceutica - Google Patents

Combinacion farmaceutica

Info

Publication number
ECSP045142A
ECSP045142A EC2004005142A ECSP045142A ECSP045142A EC SP045142 A ECSP045142 A EC SP045142A EC 2004005142 A EC2004005142 A EC 2004005142A EC SP045142 A ECSP045142 A EC SP045142A EC SP045142 A ECSP045142 A EC SP045142A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical combination
combination
airways
inhalation
sequential
Prior art date
Application number
EC2004005142A
Other languages
English (en)
Inventor
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ECSP045142A publication Critical patent/ECSP045142A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a una combinación de un inhibidor selectivo de PDE4 como se define en la presente memoria y un agonista del receptor b2-adrenérgico, para la administración simultánea, secuencial o por separado por vía inhalada en el tratamiento de una enfermedad obstructiva de las vías respiratorias u otra enfermedad inflamatoria.
EC2004005142A 2001-12-07 2004-06-07 Combinacion farmaceutica ECSP045142A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0129395.0A GB0129395D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination

Publications (1)

Publication Number Publication Date
ECSP045142A true ECSP045142A (es) 2004-07-23

Family

ID=9927247

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005142A ECSP045142A (es) 2001-12-07 2004-06-07 Combinacion farmaceutica

Country Status (33)

Country Link
US (2) US20030119862A1 (es)
EP (1) EP1455783A1 (es)
JP (1) JP2005511657A (es)
KR (1) KR20050044699A (es)
CN (1) CN1599609A (es)
AP (1) AP2004003054A0 (es)
AR (1) AR037712A1 (es)
AU (1) AU2002353255A1 (es)
BR (1) BR0214776A (es)
CA (1) CA2468676A1 (es)
CO (1) CO5590899A2 (es)
EA (1) EA200400640A1 (es)
EC (1) ECSP045142A (es)
GB (1) GB0129395D0 (es)
HN (1) HN2002000356A (es)
HR (1) HRP20040515A2 (es)
HU (1) HUP0402546A3 (es)
IL (1) IL162098A0 (es)
IS (1) IS7277A (es)
MA (1) MA27152A1 (es)
MX (1) MXPA04004930A (es)
NO (1) NO20042870L (es)
NZ (1) NZ533030A (es)
OA (1) OA12736A (es)
PA (1) PA8560601A1 (es)
PE (1) PE20031066A1 (es)
PL (1) PL370770A1 (es)
SV (1) SV2004001430A (es)
TN (1) TNSN04102A1 (es)
TW (1) TWI242433B (es)
UY (1) UY27564A1 (es)
WO (1) WO2003047578A1 (es)
ZA (1) ZA200403905B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
WO2012098495A1 (en) * 2011-01-19 2012-07-26 Glenmark Pharmaceuticals Sa Pharmaceutical composition that includes revamilast and a beta-2 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223624C (en) * 1995-06-06 2001-02-20 Pfizer Inc. Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines
NZ527232A (en) * 1998-08-26 2005-03-24 Smithkline Beecham Corp A composition contaning a PDE 4 inhibitor and a beta adrenergic bronchodilator useful for treating pulmonary diseases
TR200909479T2 (tr) * 1999-08-21 2012-02-21 Nycomed Gmbh Sinerjistik kombinasyon.

Also Published As

Publication number Publication date
HUP0402546A3 (en) 2008-04-28
AU2002353255A1 (en) 2003-06-17
TNSN04102A1 (fr) 2006-06-01
NO20042870L (no) 2004-07-06
WO2003047578A1 (en) 2003-06-12
OA12736A (en) 2006-06-29
HRP20040515A2 (en) 2004-10-31
CO5590899A2 (es) 2005-12-30
EA200400640A1 (ru) 2004-12-30
EP1455783A1 (en) 2004-09-15
PL370770A1 (en) 2005-05-30
UY27564A1 (es) 2003-07-31
CN1599609A (zh) 2005-03-23
KR20050044699A (ko) 2005-05-12
ZA200403905B (en) 2005-06-22
IS7277A (is) 2004-05-21
PE20031066A1 (es) 2003-12-24
US20030119862A1 (en) 2003-06-26
PA8560601A1 (es) 2005-02-04
US20040167153A1 (en) 2004-08-26
GB0129395D0 (en) 2002-01-30
AR037712A1 (es) 2004-12-01
CA2468676A1 (en) 2003-06-12
IL162098A0 (en) 2005-11-20
MXPA04004930A (es) 2005-04-08
SV2004001430A (es) 2004-02-24
JP2005511657A (ja) 2005-04-28
NZ533030A (en) 2007-03-30
HUP0402546A2 (hu) 2005-04-28
HN2002000356A (es) 2003-02-21
BR0214776A (pt) 2004-11-09
AP2004003054A0 (en) 2004-06-30
MA27152A1 (fr) 2005-01-03
TWI242433B (en) 2005-11-01
TW200300678A (en) 2003-06-16

Similar Documents

Publication Publication Date Title
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
CY1114139T1 (el) Πλακιδιο βουπρενορφινης για τη θεραπεια υποκαταστασης ναρκωτικων
CL2011000101A1 (es) Compuestos derivados de piridazina sustituida; inhibidores de la señalizacion hedgehog y smo; composicion farmaceutica; y uso para el tratamiento de trastornos o sindromes asociados con enfermedades hiperproliferativas.
ECSP034571A (es) Nuevas composiciones de medicamentos a base de sales de tiotropio y sales del salmeterol
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
BRPI0816255A2 (pt) Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
ATE453642T1 (de) Substituierte phenylaminopyrimidine
CL2007002875A1 (es) Composicion farmaceutica recubierta por una pelicula que comprende capecitabina y al menos un disgregante, util en el tratamiento del cancer para pacientes que tienen dificultad para tragar las formas de dosificacion solidas orales.
CY1113482T1 (el) Αναστολεις υποδοχεα σιγμα
CR7152A (es) Un inhibidor de pde4 y un agente de anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias.
CY1114933T1 (el) Στερεες φαρμακευτικες συνθεσεις σταθερης δοσης περιεχουσες ιρβεσαρτανη και αμλοδιπινη, η παρασκευη τους και η θεραπευτικη εφαρμογη τους
CY1115384T1 (el) Αντι-φλεγμονωδης συνθεση
AR058194A1 (es) Medicamentos que comprenden un agente antimuscarinico y un corticoesteroide
UY28517A1 (es) Nueva combinación
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
WO2007057221A3 (en) Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
ECSP077843A (es) Tratamiento o prevención del prurito
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
ECSP045142A (es) Combinacion farmaceutica
UY27566A1 (es) Combinación farmacéutica.
UY27565A1 (es) Combinación farmacéutica.
UY27670A1 (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinérgicos y de agentes inhibidores de la cinasa del egfr